Blog

Recent studies indicate that older mesothelioma patients tend to receive fewer chemotherapy treatments than younger patients. Researchers at the Asbestos Diseases Research Institute (ADRI) studied hundreds of patients to evaluate the correlation of survival rates and chemotherapy. The results indicated that older mesothelioma patients should receive chemotherapy treatment for higher survival rates. According to The » Read More

For patients suffering from mesothelioma, finding a treatment that works is vital. Fortunately, the options for mesothelioma treatment are advancing, including the development of inhalable treatments. Scientists at the Koch Center for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT) are working toward developing an inhalable treatment to target cancer cells located in » Read More

Immunotherapy is changing the landscape of cancer treatment. Whether on its own or in conjunction with other therapies, immunotherapy gives patients’ bodies the tools they need to destroy cancer cells. Each disease has unique markers that must be identified for a targeted treatment to be developed. Once researchers get on the right track, the results » Read More

Mesothelioma knowledge is important, information is power, and more and more people receive the bulk of their information from social media. Mesothelioma researchers are using social media to inform people exposed to asbestos about their risks, as well as to let those already diagnosed with the disease know about clinical trials and new treatment options. » Read More